Zachary Dv Abel

Zachary Dv Abel

Auto-generated profile, based on publicly available information

Zachary Dv Abel

Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Health Policy
Verified
Journal Article
Open access
ZAZachary Dv Abel
Zachary Dv Abel
Laurence RoopeLaurence Roope
Laurence Roope
RDRaymond Duch
Raymond Duch
SCSophie Cole
Sophie Cole
PCPhilip M Clarke
Philip M Clarke
Background COVID-19 vaccine hesitancy was a key barrier to ending the pandemic via mass immunisation. Objectives Assess magnitudes and differences in socioeconomic inequality in stated COVID-19 vaccine acceptance (hesitancy) and uptake. Methods Online surveys were conducted in 13 countries, collecting data from 15,337 and 18,189 respondents respectively. The investigation compares socioeconomic inequality in reported vaccine acceptance, measured in 2020-21 and subsequent uptake of vaccination in 2022. Inequalities are quantified using differences, ratios and the Erreygers adjusted concentration index. A regression decomposition approach is used to identify factors associated with inequality. Results Mean uptake levels were 87 %, while acceptance was lower at 77 %. The difference between the richest and the poorest quintile was as large as 23 percentage points in acceptance and 30 p.p. in uptake, both observed in France. Acceptance and uptake were pro-rich (regressive) in most countries. Nine countries reported pro-rich inequality in acceptance, and eight in uptake. Uptake was significantly less regressive than acceptance in Australia, China, India, and USA. Australia and Colombia were the only countries where vaccination uptake was pro-poor (progressive). Age, marital status and political ideology were correlated with socioeconomic inequalities in several countries in both waves, while gender and education were associated with acceptance, and health levels with uptake. Conclusion We found significant inequalities in vaccination acceptance and uptake across countries but inequality was generally lower in vaccine uptake than in acceptance. This suggests that inequalities can be reduced over time if adequate policies are in place to overcome hesitancy and reduce inequalities.

29 September 2026 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
ZAZachary D. V. Abel
Zachary D. V. Abel
SCSophie Cole
Sophie Cole
Guido ErreygersGuido Erreygers
Guido Erreygers
Laurence RoopeLaurence Roope
Laurence Roope
PCPhilip M. Clarke
Philip M. Clarke
Background: Randomised trials seldom investigate the impacts interventions have on socioeconomic inequality in health, focusing instead on their average treatment effects. Methods: We illustrate how standard measures of inequality such as the corrected concentration index can be reported in randomised experiments to quantify the interventions’ socio-economic distribution effect alongside more traditional average treatment effects. We illustrate this with a proof-of-concept example using a study on the impact of information and financial incentives on verified COVID-19 vaccination uptake in rural Ghana ( n = 2,271). We estimate the distributional treatment effects of informational public health messaging, low- and high-cash financial incentives relative to a placebo group and present this information on an achievement plane. Results: Health messaging had a pro-rich socioeconomic inequality impact of -0.132 [95% CI: -0.28–0.02] relative to the placebo group, while the low and high cash incentives had impacts of -0.108 [95% CI: -0.29–0.07] and − 0.081 [95% CI: -0.26–0.11] respectively, providing no significant evidence for changes in inequality relative to the placebo group. A low-cash incentive was the only intervention that was shown to increase vaccination uptake. Conclusions: A socioeconomic inequality of health distributional indicator could routinely be calculated in experimental results and presented alongside average treatment effects. This would enable the identification of whether there are equality-efficiency trade-offs. The methods presented in this paper can be used to support policy decision making with representative datasets provided there is appropriate statistical power. Trial registration: The RCT investigated in this paper was registered with the American Economic Association on January 10, 2022, RCT ID: AEARCTR-0008775.